主要文件

查看所有文档

B1636

五肽胃泌素

Name: 五肽胃泌素
Brand: SIGMA

≥95% (HPLC), powder, CCK2 receptor agonist

别名:

五肽促胃酸激素, 五肽胃泌素, N-t-Boc-β-Ala-Trp-Met-Asp-Phe酰胺

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₃₇H₄₉N₇O₉S

化学文摘社编号:

5534-95-2

分子量:

767.89

NACRES:

NA.77

PubChem Substance ID:

24891602

UNSPSC Code:

12352200

EC Number:

226-889-7

MDL number:

MFCD00076515

Assay:

≥95% (HPLC)

Form:

powder

Quality level:

200

Storage condition:

(Keep container tightly closed in a dry and well-ventilated place.)

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

产品名称

五肽胃泌素, ≥95% (HPLC), powder

Quality Level

200

assay

≥95% (HPLC)

form

powder

storage condition

(Keep container tightly closed in a dry and well-ventilated place.)

color

white to off-white

solubility

DMF: 20 mg/mL, clear, colorless to faint yellow or tan

storage temp.

−20°C

SMILES string

CSCCC(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)NC(CC(O)=O)C(=O)NC(Cc3ccccc3)C(N)=O

InChI

1S/C37H49N7O9S/c1-37(2,3)53-36(52)39-16-14-30(45)41-28(19-23-21-40-25-13-9-8-12-24(23)25)34(50)42-26(15-17-54-4)33(49)44-29(20-31(46)47)35(51)43-27(32(38)48)18-22-10-6-5-7-11-22/h5-13,21,26-29,40H,14-20H2,1-4H3,(H2,38,48)(H,39,52)(H,41,45)(H,42,50)(H,43,51)(H,44,49)(H,46,47)

InChI key

NEYNJQRKHLUJRU-UHFFFAOYSA-N

Gene Information

mouse ... Cckbr(12426)
rat ... Cckar(24889), Cckbr(25706)

说明

General description

适合研究领域：免疫学 & 细胞因子

Application

五肽胃泌素已被用于双向调节杏仁核外侧核(LA)的活力。在AR42J大鼠胰腺细胞系中，可阻断胆囊收缩素2受体(CCK2R)激动剂抑制受体与Ga-DOTA-MGS5的结合，进行细胞摄取和受体结合研究。

Biochem/physiol Actions

五肽胃泌素为人工合成的胃泌素类似物，肽链羧基末端五肽的结构与天然胃泌素一样。可作为胆囊收缩素-2(CCK2)受体/胆囊收缩素-B(CCKB)受体的激动剂。五肽胃泌素可促进胃蛋白酶和胃酸分泌，适合用于胃酸分泌功能检查。五肽胃泌素具有惊恐和焦虑作用，会导致惊恐症(PD)患者的惊恐发作。

Still not finding the right product?

Explore all of our products under 五肽胃泌素

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

常规特殊物品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Influence of gastric acid on gastric emptying and gastric distension-induced pain response in rats--effects of famotidine and mosapride.

Y Keto et al.

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society, 24(2), 147-153 (2011-11-10)

Gastroduodenal acidification has been reported to aggravate upper abdominal discomfort and pain that are symptoms suffered by functional dyspepsia (FD) patients. Delayed gastric emptying and hypersensitivity to gastric distension (GD) contribute importantly to the pathophysiology of FD. In the present

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.

L Singh et al.

Proceedings of the National Academy of Sciences of the United States of America, 88(4), 1130-1133 (1991-02-15)

The effect of neuropeptide cholecystokinin (CCK) receptor agonists and antagonists was examined in the rat elevated X-maze model of anxiety. The selective CCK-B receptor antagonists CI-988 (PD 134308) and L-365,260 produced anxiolytic-like effects, whereas MK-329, a CCK-A receptor antagonist, was

The cholecystokinin CCK2 receptor antagonist, JNJ-26070109, inhibits gastric acid secretion and prevents omeprazole-induced acid rebound in the rat.

T D Barrett et al.

British journal of pharmacology, 166(5), 1684-1693 (2012-02-04)

JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide] is a novel antagonist at cholecystokinin CCK(2) receptors with good pharmacokinetic properties and represents a novel mechanism for the treatment of gastro-oesophageal reflux disease (GORD). The purpose of the present study was to determine whether chronic treatment with

查看所有相关文献

全球贸易项目编号

货号	GTIN
B1636-100MG	04061832674551
B1636-25MG	04061833426265